Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Mar Drugs ; 20(7)2022 Jul 01.
Artículo en Inglés | MEDLINE | ID: mdl-35877734

RESUMEN

Lipid peroxidation is associated with the development of some pathologies, such as cardiovascular diseases. Reduction in oxidative stress by antioxidants, such as Arthrospira (formely Spirulina), helps improving this redox imbalance. The aim of the study was to evaluate the effect of the Arthrospira liquid extract "Spirulysat®" on oxidative markers-in particular, oxidized LDL (oxLDL)/total LDL cholesterol-and isoprostanes and to investigate its impact on lipid and glucose metabolism in the metabolic syndrome subject. A controlled, randomised, double-blind design was conducted in 40 subjects aged 18 to 65 years with metabolic syndrome after a daily intake of Spirulysat® or placebo for twelve weeks. Blood and urinary samples were collected at three visits (V1, V2, V3) in the two groups for parameters determination. Although the Spirulysat® group showed a decrease at all visits of the oxLDL/total cholesterol ratio, there was no significant difference compared to the placebo (p = 0.36). The urinary isoprostanes concentration in the Spirulysat® group was reduced (p = 0.014) at V3. Plasma triglycerides decreased at V3 (p = 0.003) and HDL-cholesterol increased (p = 0.031) at all visits with Spirulysat®. In conclusion, Spirulysat® did not change the oxidized LDL (oxLDL)/LDL ratio but decreased the urinary isoprostanes, plasma triglycerides and increased HDL cholesterol, suggesting a beneficial effect on metabolic syndrome.


Asunto(s)
Síndrome Metabólico , Spirulina , Antioxidantes/farmacología , Antioxidantes/uso terapéutico , Colesterol , HDL-Colesterol , Método Doble Ciego , Humanos , Isoprostanos/farmacología , Isoprostanos/uso terapéutico , Lipoproteínas LDL , Síndrome Metabólico/tratamiento farmacológico , Estrés Oxidativo , Extractos Vegetales/farmacología , Extractos Vegetales/uso terapéutico , Triglicéridos
2.
Mol Aspects Med ; 64: 161-168, 2018 12.
Artículo en Inglés | MEDLINE | ID: mdl-29572110

RESUMEN

ω3 Polyunsaturated fatty acids (ω3 PUFAs) have several biological properties including anti-arrhythmic effects. However, there are some evidences that it is not solely ω3 PUFAs per se that are biologically active but the non-enzymatic oxygenated metabolites of polyunsaturated fatty acids (NEO-PUFAs) like isoprostanes and neuroprostanes. Recent question arises how these molecules take part in physiological homeostasis, show biological bioactivities and anti-inflammatory properties. Furthermore, they are involved in the circulations of childbirth, by inducing the closure of the ductus arteriosus. In addition, oxidative stress which can be beneficial for the heart in given environmental conditions such as the presence of ω3 PUFAs on the site of the stress and the signaling pathways involved are also explained in this review.


Asunto(s)
Arritmias Cardíacas/tratamiento farmacológico , Ácidos Grasos Omega-3/metabolismo , Isoprostanos/metabolismo , Neuroprostanos/metabolismo , Antiasmáticos/uso terapéutico , Arritmias Cardíacas/patología , Conducto Arterial/efectos de los fármacos , Conducto Arterial/metabolismo , Ácidos Grasos Omega-3/uso terapéutico , Humanos , Inflamación/tratamiento farmacológico , Inflamación/patología , Isoprostanos/uso terapéutico , Neuroprostanos/uso terapéutico , Estrés Oxidativo/efectos de los fármacos , Transducción de Señal/efectos de los fármacos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA